Market Size and Pharmaceutical Innovation

Dubois, Pierre, de Mouzon, Olivier, Scott Morton, Fiona and Seabright, Paul (2011) Market Size and Pharmaceutical Innovation. TSE Working Paper, n. 11-232

WarningThere is a more recent version of this item available.
[img]
Preview
Text
Download (493kB) | Preview
Official URL: http://tse-fr.eu/pub/24353

Abstract

This paper quantifies the relationship between market size and innovation in the pharmaceutical industry using improved, and newer, methods and data. We find positive significant elasticities of innovation to expected market size with a point estimate under our preferred specification of 0.23. This suggests that, on average, $2.5 billion is required in additional revenue to support the invention of one new chemical entity. This magnitude is plausible given recent accounting estimates of the cost of innovation of 800 million to one billion per drug, and marginal costs of manufacture and distribution near 50%. An elasticity below 1 is also a plausible implication of the hypothesis that innovation in pharmaceuticals is becoming more difficult over time, as costs of regulatory approval rise and as the industry runs out of "low-hanging fruit".

Item Type: Monograph (Working Paper)
Language: English
Date: April 2011
Uncontrolled Keywords: Innovation, Market Size, Elasticity, Pharmaceuticals
JEL codes: L65 - Chemicals; Rubber; Drugs; Biotechnology
O31 - Innovation and Invention - Processes and Incentives
O34 - Intellectual Property Rights - National and International Issues
Subjects: B- ECONOMIE ET FINANCE
Divisions: TSE-R (Toulouse)
Institution: Université Toulouse 1 Capitole
Site: UT1
Date Deposited: 18 Jan 2012 06:03
Last Modified: 07 Mar 2018 13:22
OAI ID: oai:tse-fr.eu:24353
URI: http://publications.ut-capitole.fr/id/eprint/3571

Available Versions of this Item

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year